Maintenance Services for the NovaSeq X Plus Sequencer

The National Institutes of Health, through the Office of Logistics and Operations within the Department of Health and Human Services, is seeking to award a sole-source maintenance services contract for the NovaSeq X Plus Sequencer under solicitation number 75N98026Q00387. This presolicitation notice, issued on May 18, 2026, with a response deadline of May 28, 2026, confirms the intent to procure services exclusively from Illumina, Inc., due to the instrument’s specialized technical requirements that necessitate manufacturer-trained technicians, proprietary diagnostic tools, and original equipment manufacturer parts. The acquisition falls under FAR Part 13 Simplified Acquisition Procedures and is justified under FAR 13.106-1(b)(1), as no other source can meet the unique technical needs of the sequencer. The performance location is in Bethesda, Maryland, at the NIH facility, with an estimated contract value not exceeding the simplified acquisition threshold of $350,000. Offerors must be registered in SAM.gov, possess a valid Unique Entity Identifier and Taxpayer Identification Number, and self-certify their small business status under NAICS code 811210. Proposals must include a technical and cost submission along with required certifications and must be delivered electronically to the designated contracting officer by the deadline. No competition is anticipated, and the procurement does not include competitive evaluation factors, weighted criteria, or line-item pricing details. Packaging, marking, and preservation requirements are not specified, consistent with the nature of a service-based acquisition rather than a physical goods procurement. The contracting office, located at 6701 Rockledge Drive, Bethesda, MD 20817, is the point of contact for submissions, with Michael Falzone serving as the primary contracting officer. No contract administration details such as payment office, COR/COTR, or invoicing method are provided at this presolicitation stage.